EP Patent

EP1673135B1 — Konnektor für medizinische flüssigkeiten enthaltende verpackungen und verpackung für medizinische flüssigkeiten

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2013-01-30 · 13y expired

What this patent protects

Patent listed against ropivacaine-hydrochloride.

Drugs covered by this patent

ropivacaine-hydrochloride (ROPIVACAINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1673135B1
Jurisdiction: EP
Classification: —
Expires: 2013-01-30
Drug substance claim: No
Drug product claim: No
Assignee: Fresenius Kabi Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.